Carrie Bates - Profile and Investment Details

Investor Profile

Carrie Bates is a Venture Capital, Private Equity Firm based in Indianapolis, Indiana, United States with a diverse investment portfolio that includes companies such as Hydrocision, Celleration, Kereos, CoLucid Pharmaceuticals, MitralignGuidant Corporation/ Eli Lilly, Sirrus Technology (dba : Alluxa), CS-Keys, BioVex, Endocyte, Juventas Therapeutics, Tolera Therapeutics, Aerpio Pharmaceuticals, Remon Medical Technologies, Akebia Therapeutics, . Over time, Carrie Bates has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Carrie Bates is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Telecommunications, Life Science, Electrical Distribution, Biotechnology, Nanotechnology, Medical, Lasers, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Carrie Bates, as their portfolio suggests a familiarity and interest in this area.

Understanding Carrie Bates’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.